CONTENTS


Contents 8.


Improving integrity and excellence in cold-chain Q&A with Carmine Marotta, CEO of Dryce, who discusses the logistics involved in temperature-controlled transportation in the distribution of COVID-19 vaccines


12.


The big dilemma: Go it alone or double up? Francis Dumont, senior director, external drug product supply, at Pfizer, weighs up the pros and cons involved in outsourcing and insourcing strategies


15.


Comparator sourcing in emerging markets for global clinical trials Clinical Services International examines sourcing strategies in emerging markets, including infrastructure challenges and regulatory barriers


20.


Examining opportunities and challenges of managing collaborations with vendors Q&A with Thierry Gillard, senior clinical supply manager at Santhera, who offers his views on the challenges of outsourcing


24.


Clinical trial comparator challenges in 2021


With responses in from its Annual Survey of Clinical Trial Professionals, Abacus Medicine Pharma Services business development director Ian Hoban identifies the latest trends from the research


26.


Navigating outsourcing and contract negotiations Q&A with Santana Olomu, senior manager, clinical contracts and outsourcing, at Cytokinetics, who discusses outsourcing activities, including vendor selection, contract negotiations and budgets


4 | Clinical Trial Supply Handbook 41. 30.


Unpacking patient centricity: What it is, why it matters and how an automated patient journey makes decentralised trials easier and more patient-centric John Ristuccia, SVP of global client services at Suvoda, and colleague Andrés Escallón, VP, eCOA practice, look at how to leverage technology to meet patients’ needs


32.


CBP One: A new mobile app developed to assist with biological material importations Sean Smith, biological threat exclusion coordinator at US Customs and Border Protection, on the blockchain technology that is changing the game for clinical researchers


35.


Solving the industry’s most challenging sourcing and supply needs The extensive global reach and clinical trial solutions offered by Tanner Pharma Group


38.


How using technology and data analysis in site selection can improve trial logistics GlobalData’s director of product development, Amanda Murphy, looks at the role of data in clinical site selection


Enabling faster clinical trial timelines through an optimal supply chain Amaury Jeandrain, head of business development engineering at N-SIDE, discusses how to accelerate trial timelines by removing supply-chain bottlenecks


44.


How blockchain brings real-time visibility to clinical supply Ben Taylor, member of the Clinical Supply Blockchain Working Group, reveals how the distributed database can help make sense of supply chains


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92